|Uwe Marx||TissUse GmbH – University Berlin||Germany|
|Dinh Ngoc Duy||National University of Singapore||Singapore|
|Karolien de Wael||AXES Research Group – University of Antwerp||Belgium|
|Christoph Adelmann||Imec Leuven||Belgium|
||NASA Ames Research Center||USA|
||University of Groningen||Netherlands|
||Frost & Sullivan||USA|
||Israeli Swiss SpacePharma||Israël|
The following invited speakers have been confirmed:
|Raphaël Tomasi||Laboratoire d’Hydrodynamique (LadHyX) of Ecole Polytechnique||France|
|Per Magnus Kristiansen||Institute of Polymer Nanotechnology (INKA)||Switzerland|
|Ron Andriessen||Solliance Solar Research||Netherlands|
|Roland Zengerle||IMTEK Freiburg||Germany|
Since 2010 Uwe Marx is the CEO and founder of TissUse GmbH, a spin-out Company of the Technische Universität Berlin, Germany. The company is developing and commercializing a Multi-Organ-Chip platform. Between March 2010 and September 2015 Dr. Marx was the leader of a multi-organ-chip program at the Technische Universität Berlin. Prior to that Uwe Marx joined ProBioGen – a biotech Company he founded in 1994 – as the Chief Scientific Officer. He is a physician by training and received his doctorate degree in immunology from the Humboldt University in Berlin. He has published more than 60 peer-viewed papers and is inventor in more than 25 patent families. In addition to his current company, TissUse, he is the founder of the two successful German biotechs – Vita 34 and ProBioGen.
Christoph Adelmann obtained a Ph.D. degree in condensed matter physics from Université Grenoble Alpes in 2002 researching III-V nitride semiconductors at the CEA Grenoble. Until 2006, he was a post-doctoral research associate with the Department of Chemical Engineering and Materials Science at the University of Minnesota, focusing on spintronic materials and devices. He joined the Thin Films Group at imec in Leuven, where he is currently a principal member of technical staff, focusing on metallic and dielectric materials for logic, interconnects, and memory and on novel devices for nanoelectronic applications. He has co-authored over 240 scientific publications in peer-reviewed journals or conference proceedings as well as 7 granted patents and 25 pending patent applications.
Dr. Govind Kaigala is a Research Staff Member at the Laboratory of IBM in Zurich. He is currently leading activities on liquid-based non-contact scanning probe technologies – microfluidic probe – and is championing new concepts on “open space” microfluidics and “tissue microprocessing”. These research activities are driven by specific technological needs in the field of personalized medicine.
He is passionate about translational clinical/medical research and strives to bring in quantitation in biology by leveraging micro- and nanosystems assays for microchip-based chemical and biomolecular analysis.
Previously, he was an NSERC postdoctoral fellow at the microfluidics laboratory in Mechanical Engineering and Urology at Stanford University, USA. Dr. Kaigala received his Ph.D (Electrical Engineering and Oncology) and M.Eng from the University of Alberta, Canada. Dr. Kaigala has authored and co-authored 47 scientific publications, 70 conference papers, 1 book, and 30 patent families. In addition to IBM and other industrial entities, his work is supported by the European Research Council, the European Union and Swiss National Science Foundation. He is the recipient of several IBM awards, including Research Division Accomplishment Award in 2014 & 2017, the Horizon Alumni Award from the University of Alberta, and he is a Senior Member of IEEE.
Ngoc Duy is a Ph.D candidate at Department of Biomedical Engineering (BME), National University of Singapore (NUS). He will finish his study in December, 2018. Before, NUS, he was the scientist in Miniaturisation for Life Sciences Group, Institute of Analytical Science, Dortmund, Germany, focusing on Brain-on-Chip project collaboration with Dr. Jean-Michel. Peyrin (neurobiologist, Institute of Biology Paris-Seine, France) who founded the MicroBrain Biotech company and Neurotoxicology and Chemosensation Group, Leibniz Insititute, Germany. The works were published on Lab Chip, JoVE, Springer Book. The team sent out the chips for first ordering to Prof Tsuneya Ikezu, MD, PhD, Department of Pharmacology & Experimental Therapeutics and Neurology, Alzheimer’s Disease Center, Boston University School of Medicine.
In NUS, he develops a novel NIR laser 3D bioprinting for constructing tissues or organs. The work was published on Small, Wiley. It was selected cover feature and highlighted in AdvancedScienceNews (Wiley) and several 3D Bioprinting media from industry. Our NIR laser 3D Bioprinting technology has been attracted by several 3D Bioprinting start-up companies. We are negotiating with Fluxbio, a 3D Bioprinting start-up company based on Electrospray technology for commercial.
Duy has authored and co-authored prestigious scientific publications on Nature Communications, Advanced Functional Materials, Small, Lab-on-a-Chip, 1 book chapter, and 1 patent. He got the award from The Chemical and Biological Microsystems Society (CBMS) and sort list (4/130) the Federation of Analytical Chemistry and Spectroscopy Societies (FACSS) innovation award.
Raphaël TOMASI graduated from the ESPCI Paris in 2013 with an engineering degree as well as a research master in microfluidics. He gained his PhD (untitled ‘Multiscale cytometry of 3D cell cultures in microfuidic hydrogel droplet arrays’) from the hydrodynamics laboratory (LadHyX) of the Ecole Polytechnique (Paris area) in 2016, under the supervision of Charles BAROUD.
Raphaël is currently working as a post-doc for moving this technology, protected by several patents on which he is co-inventor, to the market through a start-up project. The aim is to provide a plug-and-play platform for allowing researchers performing complex protocols and analysis with spheroids at high-throughput. This technology is expected to have a strong impact in drug development, in vitro toxicity testing and personalized medicine.